SibBioTechnology Inc is a biopharmaceutical consulting company. We are focused on biotechnology commercialization via partnering with venture capital and major biotech and pharmaceutical companies. Our product development strategy focuses on therapeutic applications of DNA vaccines and RNA-based biomolecules.

SibBioTechnology discovers, develops and delivers innovative human therapeutics as well as provides strategy-through-implementation consultancy specializing in the life sciences. We couple scientific expertise with a keen understanding of the global life sciences marketplace. As the market for oligonucleotide-based medicines continues to grow, SibBiotechnology will stay committed to introducing novel products, while maintaining its existing products and investment portfolio.

Our strategy is to move most advanced biotechnological research from idea to clinics. With a broad pipeline of candidate medicines, SibBioTechnology remains committed to advancing science to improve people’s lives. Our goal is to help our clients develop and implement actionable strategies that generate sustainable growth, effectiveness and a global competitive advantage.

Investor Relations please contact at corporate@SibBioTechnology.com

©2008 SibBioTechnology, Inc. All Rights Reserved